Skip to main navigation Skip to search Skip to main content

Development of second-generation indole-based dynamin GTPase inhibitors

  • Christopher P. Gordon
  • , Barbara Venn-Brown
  • , Mark J. Robertson
  • , Kelly A. Young
  • , Ngoc Chau
  • , Anna Mariana
  • , Ainslie Whiting
  • , Megan Chircop
  • , Phillip J. Robinson
  • , Adam McCluskey

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)

Abstract

Focused library development of our lead 2-cyano-3-(1-(3-(dimethylamino) propyl)-2-methyl-1H-indol-3-yl)-N-octylacrylamide (2) confirmed the tertiary dimethylamino-propyl moiety as critical for inhibition of dynamin GTPase. The cyanoamide moiety could be replaced with a thiazole-4(5H)-one isostere (19, IC50(dyn I) = 7.7 μM), reduced under flow chemistry conditions (20, IC50(dyn I) = 5.2 μM) or replaced by a simple amine. The latter provided a basis for a high yield library of compounds via a reductive amination by flow hydrogenation. Two compounds, 24 (IC50 (dyn I) = 0.56 μM) and 25 (IC50(dyn I) = 0.76 μM), stood out. Indole 24 is nontoxic and showed increased potency against dynamin I and II in vitro and in cells (IC50(CME) = 1.9 μM). It also showed 4.4-fold selectivity for dynamin I. The indole 24 compound has improved isoform selectivity and is the most active in-cell inhibitor of clathrin-mediated endocytosis reported to date.
Original languageEnglish
Pages (from-to)46-59
Number of pages14
JournalJournal of Medicinal Chemistry
Volume56
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Dive into the research topics of 'Development of second-generation indole-based dynamin GTPase inhibitors'. Together they form a unique fingerprint.

Cite this